首页> 外文会议>International Conference on Physics and Chemistry of Materials in Novel Engineering Applications >Binding performance of phytochemicals with mutant threonine-protein kinase Chk2 protein: An in silico study
【24h】

Binding performance of phytochemicals with mutant threonine-protein kinase Chk2 protein: An in silico study

机译:用突变体苏氨酸 - 蛋白激酶CHK2蛋白的植物化学物质的结合性能:硅研究中

获取原文

摘要

The checkpoint kinase-2 (CHEK2) belongs to protein kinase super family. It regulates the checkpoint capture through phosphorylation in cell cycle and inhibit the activity of CDC25A, CDC25B and CDC25C genes. Herein, we analyzed the binding site and binding energy of the protein with different phytochemicals. In the present work, we have studied the structural stability of mutant FHA domain of CHEK2 encoded protein as well as binding mechanism with bosutinib drug and phytochemicals likes epigallocatechin and epicatechin by molecular docking. From the molecular docking study it was found that, phytochemicals have highest binding energy with mutant FHA domain of CHEK2 encoded protein as compare to bosutinib drug. Both the studied phytochemicals showing inhibitory effects against mutant CHEK2 encoded protein.
机译:检查点激酶-2(Chek2)属于蛋白激酶超级家庭。 它通过细胞周期中的磷酸化来调节检查点捕获,并抑制CDC25A,CDC25B和CDC25C基因的活性。 在此,我们分析了具有不同植物化学物质的蛋白质的结合位点和结合能量。 在目前的工作中,我们研究了Chek2编码蛋白质的突变体FHA结构域的结构稳定性,以及具有培替尼药物和植物化学的结合机制喜欢EpigallocateChin和EpicaTechin通过分子对接。 从分子对接研究中发现,植物化学物质与Chek2编码蛋白的突变体FHA结构域具有最高的结合能量,与Bosutinib药物相比。 研究的植物化学症均显示对突变体Chek2编码蛋白的抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号